About Aerogen
Aerogen is a Healthcare company based in Galway (Ireland) founded in 1997 by John Power, and was acquired by Nektar in August 2005. Vibrating mesh nebulizers are manufactured for aerosol drug delivery. Aerogen has raised $18 million across 4 funding rounds from investors including J P Morgan, Temasek and European Union. Its chief executive, as recorded, is John Power. Its website aerogen.com draws about 14 thousand monthly visits. Its Indian entity Aerogen Medical Devices India Private Limited reported revenue of ₹4.73 Cr. Aerogen offers products and services including Aerogen Solo and Aerogen Ultra. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices.
Company details
Aerogen was established in 1997 in Galway, Ireland, within the medical devices sector. Vibrating mesh nebulizers are produced for aerosol drug delivery in respiratory therapy applications. These devices support invasive and non-invasive mechanical ventilation, high-flow systems, and self-ventilating methods. Single-patient-use options, handheld units, controllers, and accessories are offered for compatibility with various respiratory equipment.
- Headquarters Galway, Ireland
- Founders John Power
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website aerogen.com
- Social LinkedIn X Facebook YouTube
- Acquired by Nektar (Aug 2005)
- Legal Name Aerogen Medical Devices India Private Limited
- Date of Incorporation 17 Dec, 2019
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹4.73 Cr
FY 2025 · -36% YoY
- Indian entity net loss-₹5.04 Cr
FY 2025 · -107% margin
- Indian entity EBITDA-₹5.02 Cr
FY 2025 · -106% margin
- Total Equity Funding$18M (USD)
in 4 rounds
- Latest Funding Round$94.83K (USD), Grant
Jun 2022
- InvestorsJ P Morgan
& 7 more
- Acquired byNektar
(Aug 2005)
Associated legal entities of Aerogen
Aerogen operates through Aerogen Medical Devices India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aerogen Medical Devices India Private Limited CIN U51909DL2019PTC358844 | Active | 17 Dec 2019 | New Delhi, Delhi | ₹4.7 Cr | 2 | View details |
Products & Services of Aerogen
Aerogen offers a comprehensive portfolio of products and services, including Aerogen Solo and Aerogen Ultra.
Aerogen Solo is employed as a single-patient-use device that facilitates aerosol drug delivery across stages of respiratory therapy, including invasive and non-invasive ventilation.
Aerogen Ultra is utilized as a handheld device in conjunction with other products to support inhalation treatments during respiratory exacerbations or post-ventilation scenarios.
Apps and channels of Aerogen
its YouTube channel AerogenLtd has 1.16K subscribers and 30 videos.
Videos from Aerogen
The most watched videos on Aerogen's YouTube channel, AerogenLtd (1.16K subscribers). Click a video to play it here.
More on AerogenLtd.
Funding Insights of Aerogen
Aerogen has successfully raised a total of $18M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $94.83 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18M
- Total Rounds 4
- Last Round Grant — $94,827
- First Round $18M
(Sep 1998)
- Investors Count 7
All 4 funding rounds of Aerogen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $94,827 | Grant | – | – | |
| Jan 2020 | $236,369 | Grant | – | – | |
| Jan 2019 | $11.46M | Post-IPO | – | – | |
| Sep 1998 | $18M | Series A | – | – |
8 investors in total: 8 institutional.
Investors in Aerogen
Aerogen has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include J P Morgan, Temasek and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm that focuses on early stage investments in the US | usvp.com | Menlo Park, United States | ||
Early-stage investing in IT and healthcare ventures. | interwest.com | |||
Tech-based companies are invested in by Wheatley Partners. | wheatleypartners.com | Great Neck, United States | ||
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Comprehensive financial services are provided to corporations and individuals. | 1799 | jpmorgan.com | New York, United States | |
Fund based investment management firm and fund of funds focused on multiple sectors | 1935 | invescomutualfund.com | Mumbai, India | |
Therapeutics for multiple diseases are developed using PEGylation platforms. | 1990 | nektar.com | San Francisco, United States |
Investor details for Aerogen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Aerogen Medical Devices India Private Limited (Aerogen)
Aerogen Medical Devices India Private Limited is the primary company behind Aerogen. The board of Aerogen Medical Devices India Private Limited currently have 2 directors; the longest-serving is Debabrata Bhowmick, appointed in 2024. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Debabrata Bhowmick DIN 08743773 | Director | 11 Nov 2024 | 1 yr 11 mo | Aerogen Medical Devices India Private Limited |
| Mark Anthony Lydon DIN 10875029 | Director | 17 Dec 2024 | 1 yr 10 mo | Aerogen Medical Devices India Private Limited |
People of Aerogen
10 people are tracked at Aerogen (4 in leadership, 4 in board & advisors, 2 in team).
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership | |
Alaa Asi | Commercial Sales Director , MEA Region | Leadership |
Dave Mescal | Head Of People & Organisational Development | Leadership |
Francois Scott Schmidt | Chief Commercial Officer (cco) | Leadership |
Bernard Collins | Chairman | Board & advisors |
Jane E. Shaw | Board Member | Board & advisors |
John O'Dea | Board Member | Board & advisors |
Ethan Park | Board Member | Board & advisors |
Lorna Nolan | Global Talent Acquisition Lead | Team |
Brett Rodriguez | Account Manager | Team |
Complete people profiles for Aerogen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Aerogen
Figures of Aerogen Medical Devices India Private Limited, the primary company behind Aerogen, for FY 2025. Revenue was ₹4.73 Cr (-36% year on year). Net loss was -₹5.04 Cr (-107% margin). EBITDA was -₹5.02 Cr (-106% margin). Revenue has grown at a compounded annual rate of -13% over three years.
- ₹4.73 CrRevenue · FY 2025 · -36% YoY
- -₹5.04 CrNet loss · -107% margin
- -₹5.02 CrEBITDA · -106% margin
- ₹28.50 CrPaid-up capital
- -13%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Aerogen Medical Devices India Private Limited are on its company page.
Detailed financial statements for Aerogen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Aerogen
5 dated milestones of Aerogen across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Aerogen is founded.
- Funding First funding round of $18.0M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Nektar.
- Funding Latest funding round, Grant, of $95K.
Web traffic of Aerogen
The website of Aerogen (aerogen.com) receives about 14.3K visits a month.
- Monthly visits14.3K
▲ 4.9% vs previous month
Websites whose visitors overlap most with Aerogen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| microlife.com | 100% | 57.4K | #611,658 | View details | |
devilbisshc.com | devilbisshc.com | 89% | – | ||
forum.mukowiscydoza.pl | forum.mukowiscydoza.pl | 80% | – | ||
| evergreen-nebulizers.co.uk | 80% | #2,990,170 | View details | ||
eden-mobility.co.uk | eden-mobility.co.uk | 64% | #505,322 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Aerogen
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aerogen
Complete news archive for Aerogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aerogen
Aerogen was founded in 1997 and raised its 1st funding round 1 year after it was founded.
Aerogen is headquartered in Galway, Ireland.
John Power is the CEO of Aerogen, as recorded in our data. They have also founded this company.
Aerogen is a funded company, having raised a total of $18M across 4 funding rounds to date. The company's 1st funding round was a Series A of $18M, raised on Sep 1998.
The primary company behind Aerogen, Aerogen Medical Devices India Private Limited, reported revenue of ₹4.73 Cr for FY 2025, down 36% year on year.
Aerogen was established in 1997 in Galway, Ireland, within the medical devices sector. Vibrating mesh nebulizers are produced for aerosol drug delivery in respiratory therapy applications. These devices support invasive and non-invasive mechanical ventilation, high-flow systems, and self-ventilating methods. Single-patient-use options, handheld units, controllers, and accessories are offered for compatibility with various respiratory equipment.
Aerogen offers Aerogen Solo and Aerogen Ultra.
Aerogen has 8 investors. Key investors include J P Morgan, Temasek, European Union, Invesco Mutual Fund, and Nektar.
Aerogen operates through Aerogen Medical Devices India Private Limited.
Yes. Aerogen was acquired by Nektar in August 2005.
The legal entities of Aerogen currently have 2 directors, including Debabrata Bhowmick, Mark Anthony Lydon.